Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

NeurogesX Announces New PDUFA Date For Qutenza(TM) New Drug Application
NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that the United States Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) date from August 16, 2009 to November 16, 2009 to review the new drug application (NDA) for Qutenza(TM) to manage pain associated with postherpetic neuralgia (PHN).
generic viagra online
Caffeine Equal To 5 Cups Of Coffee A Day Reversed Alzheimer's Signs In Mice
New research from the US and Japan showed that giving the caffeine equivalent of five cups of coffee a day to aged mice with symptoms of
News of the day
Inviragen Researching Vaccines To Protect Against Pandemic And Seasonal Influenza Viruses
Based on its ongoing avian influenza vaccine research, Inviragen is designing vaccines to protect against multiple influenza strains, including seasonal influenza and the recently emerged H1N1 influenza strain. The H1N1 influenza virus has caused nearly 30,000 cases worldwide in 74 countries leading to 144 deaths. In contrast, while no H5N1 avian influenza strain capable of human-to-human transmission has yet emerged, the high mortality of the virus represents a threat for future epidemics. In addition, conventional seasonal influenza continues to impact public health, causing an estimated 250,000 deaths worldwide every year. Inviragen will leverage its success in designing avian influenza vaccines to identify vaccine candidates that protect against pandemic and seasonal influenza viruses.
Diagnostics

Care For School Children With Diabetes May Be Improved By Telemedicine

Type 1 diabetes is the most common chronic childhood disease. The management of this serious medical condition includes regular fingerstick glucose measurements, multiple daily injections of insulin, and frequent insulin dose adjustments. Because children spend a great deal of their time in school, school nurses often supervise medical decisions and diabetes care. Some researchers believe that the use of telecommunication technology may make diabetes care easier for some children. A new study soon to be published in the Journal of Pediatrics explores the effectiveness of telemedicine in helping school nurses and children manage diabetes care. Dr. Roberto Izquierdo and colleagues from SUNY Upstate Medical University in Syracuse, NY, studied 41 children between the ages of 5 and 14 years with type 1 diabetes. All of the children received routine care, and 23 of the 41 children were also enrolled in a telemedicine intervention program. As a part of routine care, letters containing instructions for each child"s diabetes care were sent to the school nurses, who also attended an annual diabetes education program. Additionally, all children visited the diabetes center at SUNY Medical University every three months, and parents, children, and school nurses communicated with the center via phone as needed. In addition to receiving regular care, the 23 children enrolled in the telemedicine intervention program attended video conferences with the school nurse and the diabetes center monthly to discuss treatment orders. Their glucose readings were sent to the center via the telemedicine unit, and the diabetes nurse practitioners at the center made adjustments to insulin treatments as needed. During the initial six month period of use, the telemedicine group experienced improved blood sugar control and fewer visits to the Emergency Department and/or hospitalizations due to their diabetes. The telemedicine program was well accepted by the participants, with more than 90% stating they would use the program again. According to Dr. Izquierdo, "Children in the telemedicine treatment group were more apt to feel better about their diabetes." He also notes that the children who used the telemedicine program were more likely to complete the prescribed diabetes care related tasks, which can lead to improved management of the disease. Dr. Izquierdo and his colleagues are hopeful that school telemedicine programs could improve diabetes care in the future. The study, reported in "School-Centered Telemedicine for Children with Type 1 Diabetes Mellitus" by Roberto Izquierdo, MD, Philip C. Morin, MS, CCRP, Kathleen Bratt, PNP, CDE, Zoryana Moreau, FNP, CDE, Suzanne Meyer, RN, CDE, Robert Ploutz-Snyder, PhD, Michael Wade, MS, and Ruth S. Weinstock, MD, PhD, appears in The Journal of Pediatrics, DOI 10.1016/j.jpeds.2009.03.014, published by Elsevier. Brigid Huey Elsevier Health Sciences


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009